EWBC Stock East West Ban (EWBC, $100.23) Moving Average Convergence Divergence (MACD) Histogram turned negative on February 7, 2025

GET DAILY SIGNALS

Get AI intraday signals

EWBC - East West Bancorp

MACD signal

View

Odds of DOWN Trend

Price: $100.23

Daily change: -$1.84 (-1.8%)

Daily volume: 527.9K

Capitalization: $13.9B

Industry: Regional Banks

EWBC sees MACD Histogram just turned negative

EWBC saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on February 07, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 47 instances where the indicator turned negative. In of the 47 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 03, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on EWBC as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

EWBC moved below its 50-day moving average on February 07, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for EWBC crossed bearishly below the 50-day moving average on February 19, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EWBC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for EWBC's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EWBC advanced for three days, in of 329 cases, the price rose further within the following month. The odds of a continued upward trend are .

EWBC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 310 cases where EWBC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 62, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. EWBC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.572) is normal, around the industry mean (1.030). P/E Ratio (9.538) is within average values for comparable stocks, (18.662). Projected Growth (PEG Ratio) (4.719) is also within normal values, averaging (2.366). Dividend Yield (0.025) settles around the average of (0.058) among similar stocks. P/S Ratio (4.318) is also within normal values, averaging (2.921).